V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290008359 | 290004620 | null | 60.8 | Palliative (P) | 2018-02-13 | 2018-04-30 | Trastuzumab + VINORELBINE | N | N | 290017408 | NOT MATCHED |
| 290008360 | 290004638 | 1.52 | null | Palliative (P) | 2015-09-13 | 2015-09-13 | CAPECITABINE + CISPLATIN + MITOMYCIN | N | null | 290017567 | LANREOTIDE |
| 290008361 | 290006971 | 1.81 | 40.4 | Palliative (P) | null | 2018-07-18 | CAPECITABINE + MITOMYCIN + RT | 02 | null | 290017662 | CARBOPLATIN + PACLITAXEL |
| 290008362 | 290004705 | 0 | 50.3 | Palliative (P) | 2016-02-28 | 2016-04-25 | Carboplatin AUC 2 - 5 | N | null | 290018167 | CAPECITABINE |
| 290008363 | 290004715 | 1.73 | null | Palliative (P) | 2019-03-06 | 2019-03-07 | CISPLATIN + RT | 99 | N | 290018209 | OCTREOTIDE |
| 290008364 | 290004724 | 1.65 | null | Palliative (P) | 2015-07-20 | 2015-08-09 | Trial Unspecified | N | N | 290018248 | CARBOPLATIN + PACLITAXEL |
| 290008365 | 290004727 | 1.67 | null | Palliative (P) | 2017-08-03 | 2017-09-25 | Capecitabine + Oxaliplatin 21day | N | N | 290018249 | CAPECITABINE |
| 290008366 | 290004733 | 1.7 | 95 | Palliative (P) | 2017-06-15 | 2017-06-15 | CAPECITABINE + TEMOZOLOMIDE | 02 | Y | 290018280 | CAPECITABINE + OXALIPLATIN |
| 290008368 | 290007018 | null | 118 | Palliative (P) | 2017-09-05 | 2017-09-05 | Capecitabine | 02 | N | 290018470 | OCTREOTIDE |
| 290008369 | 290007019 | 1.78 | 65 | Curative (C) | 2014-10-26 | 2014-10-26 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 290018476 | CAPECITABINE + OXALIPLATIN |
| 290008370 | 290004793 | 1.81 | 33.5 | Disease modification (D) | 2019-04-03 | 2019-08-22 | CABOZANTINIB | 02 | N | 290018681 | LANREOTIDE |
| 290008371 | 290004843 | 0 | 53.2 | Palliative (P) | 2018-09-30 | 2018-10-03 | CAPECITABINE + MITOMYCIN + RT | 2 | N | 290019011 | GEMCITABINE |
| 290008372 | 290004848 | 1.6 | 65 | Palliative (P) | 2016-09-16 | 2016-09-16 | EC | N | N | 290019042 | IPILIMUMAB |
| 290008373 | 290004854 | 1.78 | 97 | Palliative (P) | 2015-04-20 | 2015-08-12 | Cetuximab + Radiotherapy Maint | N | N | 290019084 | CAPECITABINE + CARBOPLATIN |
| 290008374 | 290004870 | 1.65 | 52 | Palliative (P) | 2015-03-09 | 2015-03-24 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290019178 | LANREOTIDE |
| 290008375 | 290004890 | 1.78 | 98 | Palliative (P) | 2014-09-23 | 2014-09-23 | LANREOTIDE | 02 | N | 290019304 | CAPECITABINE |
| 290008376 | 290004900 | 1.6 | 53.5 | Palliative (P) | 2018-10-28 | 2018-10-28 | Cetuximab 7 day (>Cycle 2) | 02 | N | 290019407 | CISPLATIN + RALTITREXED + TRASTUZUMAB |
| 290008377 | 290004961 | 1.79 | 95 | Palliative (P) | 2015-10-03 | 2015-10-06 | CARBOPLATIN | N | Y | 290019795 | CARBOPLATIN + PACLITAXEL |
| 290008378 | 290004982 | null | null | Palliative (P) | 2018-05-19 | 2018-10-06 | Capecitabine + Oxaliplatin 21day | N | Y | 290019956 | LANREOTIDE |
| 290008379 | 290005011 | 1.76 | 80 | Palliative (P) | 2015-05-05 | 2015-09-27 | Docetaxel 75mg/m2 (21 day) | N | N | 290020157 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008380 | 290005045 | 1.64 | null | Curative (C) | 2017-12-27 | 2018-02-18 | Capecitabine | null | null | 290020351 | CAPECITABINE + MITOMYCIN + RT |
| 290008381 | 290005052 | 1.69 | null | Palliative (P) | 2019-06-12 | 2019-06-12 | CISPLATIN + FLUOROURACIL + RT | N | N | 290020378 | MELPHALAN |
| 290008382 | 290005062 | 1.84 | 72.4 | Palliative (P) | null | 2016-12-30 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | N | N | 290020394 | MCX |
| 290008383 | 290005068 | 1.67 | null | Palliative (P) | 2017-06-30 | 2017-07-15 | Bevacizumab + Oxaliplatin +MdG | N | N | 290020421 | CISPLATIN |
| 290008384 | 290005083 | 1.63 | 56.1 | Palliative (P) | 2017-05-02 | 2017-05-02 | Trial Unspecified | N | N | 290020514 | OCTREOTIDE |
| 290008385 | 290005091 | 0 | 73.8 | Palliative (P) | 2016-09-15 | 2017-07-22 | Trial Unspecified | 02 | N | 290020545 | OCTREOTIDE |
| 290008386 | 290005103 | null | 70.7 | Palliative (P) | 2017-06-14 | 2017-06-16 | LANREOTIDE | 02 | Y | 290020596 | CARBOPLATIN |
| 290008387 | 290005115 | 0 | 65.75 | Curative (C) | 2017-09-24 | 2018-04-02 | Capecitabine | N | N | 290020635 | R IVAC |
| 290008388 | 290007153 | 1.5 | null | Palliative (P) | null | 2017-07-18 | Carboplatin AUC 6 - 10 | N | N | 290020638 | ECX |
| 290008389 | 290005126 | 1.6 | null | Palliative (P) | null | 2017-12-23 | Cisplatin 100 + RT(H&N) 1 day | null | null | 290020664 | SUNITINIB |
| 290008390 | 290005218 | 1.57 | 63.35 | null | 2015-04-15 | 2015-04-30 | CARBOPLATIN + RT | N | N | 290021172 | CAPECITABINE |
| 290008391 | 290005250 | 1.57 | null | Curative (C) | 2016-02-18 | 2016-04-25 | CARBOPLATIN + ETOPOSIDE | Y | N | 290021292 | CAPECITABINE + MITOMYCIN + RT |
| 290008392 | 290005267 | 1.87 | null | Palliative (P) | 2016-04-30 | 2016-07-10 | CETUXIMAB + RT | 02 | N | 290021389 | OCTREOTIDE |
| 290008393 | 290005281 | 1.72 | null | Curative (C) | 2018-03-08 | 2018-03-21 | CVP R | 02 | N | 290021439 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008394 | 290005299 | null | 72.7 | Curative (C) | null | 2018-07-10 | CAPECITABINE + RT | 02 | N | 290021522 | CAPECITABINE + MITOMYCIN + RT |
| 290008395 | 290005317 | null | 90 | null | null | 2019-02-23 | CARBOPLATIN + PACLITAXEL | 02 | N | 290021596 | CISPLATIN + RT |
| 290008396 | 290005327 | 1.52 | 73.7 | Palliative (P) | 2016-07-01 | 2016-09-14 | Cetuximab 7 day (Cycle 1) | 2 | N | 290021659 | OXALIPLATIN |
| 290008397 | 290005330 | null | null | Palliative (P) | 2019-05-19 | 2019-07-12 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 290021673 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008398 | 290005339 | 1.59 | null | Neo-adjuvant (N) | 2017-03-03 | 2017-03-23 | Bortezomib +/- Dexamethasone | null | null | 290021733 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008399 | 290005347 | 1.6 | 56.4 | Palliative (P) | null | 2017-06-02 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 290021744 | CETUXIMAB + CISPLATIN + FU |
| 290008400 | 290005351 | 1.62 | 55.9 | Palliative (P) | 2019-03-15 | 2019-04-03 | CAPECITABINE + TEMOZOLOMIDE | N | N | 290021748 | CAPECITABINE + OXALIPLATIN |
| 290008401 | 290005371 | null | 82.2 | Curative (C) | 2018-02-18 | 2018-03-12 | Sunitinib | N | Y | 290021820 | FLUOROURACIL + MITOMYCIN |
| 290008402 | 290005384 | 1.64 | 70 | null | 2018-11-19 | 2018-12-21 | CAPECITABINE + OXALIPLATIN | N | null | 290021886 | CARBO + FLUOROURACIL |
| 290008403 | 290005390 | null | 53.3 | Curative (C) | 2016-11-02 | 2016-11-08 | Rituximab | Y | N | 290021906 | CETUXIMAB |
| 290008404 | 290005393 | 1.68 | 78.8 | Adjuvant (A) | 2018-12-12 | 2018-12-17 | LANREOTIDE | 2 | N | 290021951 | CAPECITABINE + OXALIPLATIN |
| 290008405 | 290007286 | null | 107 | Palliative (P) | 2016-11-12 | 2016-11-13 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | 290021981 | CAPECITABINE + RT |
| 290008406 | 290008419 | null | null | Palliative (P) | 2019-01-11 | 2019-01-12 | Capecitabine | N | null | 290022185 | PEMBROLIZUMAB |
| 290008407 | 290005437 | 1.64 | 87.9 | Neo-adjuvant (N) | null | 2018-09-05 | MCX | N | N | 290022214 | CAPECITABINE + OXALIPLATIN |
| 290008408 | 290005471 | 1.76 | 93 | Palliative (P) | 2017-01-09 | 2017-01-09 | Cisplatin + Radiotherapy | 2 | N | 290022373 | EVEROLIMUS |
| 290008409 | 290005487 | 1.64 | 64.2 | Palliative (P) | 2017-08-12 | 2017-08-19 | CARBOPLATIN + ETOPOSIDE | 02 | N | 290022420 | GEMCITABINE |